Canara HSBC Life IPO is a bookbuilding offer scheduled from October 10 to 14, 2025, featuring a price band of ₹100 – ₹106 per share for 23.75 crore equity shares. Post-listing, the company will remain a strong player in the life insurance sector, backed by significant bancassurance channels and strategic promoter support. Canara HSBC Life IPO aims to deliver exit opportunities for existing shareholders while maintaining a strong footprint in bancassurance-led distribution and digital transformation.
₹00
₹106
₹
Expert Opinions
Canara HSBC Life IPO is attracting positive market sentiment, reflecting confidence in the company’s strong bancassurance partnership and established presence in India’s private life insurance sector. The strengths include a diverse product portfolio, robust claim settlement ratios, and strategic ties with leading banks, ensuring sustained distribution and customer access. Risks remain due to regulatory changes in insurance, ongoing competition, and relatively low recent revenue growth, which could affect long-term margins.
In valuation analysis for Financial Year 2025, Canara HSBC Life IPO records Return on Equity (ROE) at 7.71%, Return on Net Worth (RONW) at 7.97%, and Net Asset Value (NAV) of 15.97, positioning it moderately within sector benchmarks. Over the long term, Canara HSBC Life IPO offers investment appeal due to digital initiatives, backing from reputable promoters, and steady expansion plans, but investors should weigh sector challenges and profitability before committing funds.
Investor Considerations
Investors considering the Canara HSBC Life IPO should note the company’s solid performance and sound fundamentals, with revenue and profit growth supporting its stable position in the life insurance sector. The insurance sector remains optimistic due to rising awareness and increasing demand for life coverage. In terms of valuation for Financial Year 2025, Canara HSBC Life IPO reports an Earnings Per Share (EPS) of ₹1.23 (Basic) and an EBITDA margin of 1.87%, reflecting its operational efficiency.
The company exhibits promising growth prospects driven by bank-led distribution and expanding individual weighted premium income. Risk factors include regulatory changes, intense competition, and sensitivity to economic cycles. For investment horizon, short-term investors should watch for listing-day volatility, while long-term investors may benefit from the company’s growth potential and strategic partnerships, making the IPO attractive for a balanced portfolio focused on insurance sector exposure.
| Date | GMP | Trend |
|---|---|---|
| 15 Oct 2025 10.53 | ₹00 | --- |
| 14 Oct 2025 11.51 | ₹00 | --- |
| 13 Oct 2025 20.00 | ₹00 | Down |
| 12 Oct 2025 17.30 | ₹2 | --- |
| 11 Oct 2025 11.17 | ₹2 | Up |
| 10 Oct 2025 15.57 | ₹00 | Down |
| 09 Oct 2025 11.00 | ₹10 | --- |
| 08 Oct 2025 18.03 | ₹10 | Up |
| 07 Oct 2025 13.15 | ₹00 | --- |
| 06 Oct 2025 19.38 | ₹00 | --- |
FAQs
Canara HSBC Life IPO Current GMP is ₹00.
Canara HSBC Life IPO Expected Returns is 0.00%.
Canara HSBC Life IPO estimated listing price is ₹106.